Adelaide researchers have published the world’s first study documenting the lived experience of childhood glaucoma in adults, which they hope will lead to a first-of-its-kind quality of life (QoL) tool for the rare condition.
Read More
New study lends weight to pandemic and myopia link
A Hong Kong study highlighting a significant decrease in the time schoolchildren have been able to spend outdoors and a sharp increase in screen time is the latest to join mounting evidence that a rise in childhood myopia may be linked to the coronavirus pandemic.
Read More
Read More
Gene therapy trial for dry AMD under way in Australia
Australia’s first clinical trials of an investigational gene therapy for dry age-related macular degeneration (AMD) has commenced at the Centre for Eye Research Australia (CERA).
Read More
Read More
Roche’s faricimab meets primary endpoint in DME trial
Swiss drug giant Roche is poised to pursue regulatory clearance for its new faricimab antibody for diabetic macular edema (DME) after it produced a similar effect to Eylea in twin clinical trials, but with half the dosing regimen in several patients.
Read More
Read More
Race to identify inherited retinal disease patients for gene therapies
Australian researchers are using genetic testing to identify as many people as possible with inherited retinal disease (IRD), in preparation for an influx of life-changing gene and stem cell therapies expected over the next decade.
Read More
Read More
Australian glaucoma trial set to expand after vitamin B3 success
Daily doses of vitamin B3 can lead to significant improvements in glaucoma patients who are also receiving regular treatments to lower eye pressure, new results of a world-first study have revealed.
Read More
Read More
Aussie study targets at-risk relatives of glaucoma patients
Preliminary results of a study targeting the most at-risk relatives of glaucoma patients suggest approximately 38% have the disease or have suspicious signs and require close monitoring.
Read More
Read More